Clustering Deviation Index (CDI): A robust and accurate unsupervised measure for evaluating scRNA-seq data clustering
Jiyuan Fang(Duke University), Jichun Xie(University of Minnesota), Cliburn Chan(Duke University), Liuyang Wang(Zhejiang Medicine (China)), Qi-Jing Li(Agency for Science, Technology and Research), Diyuan Qin(Sichuan University), Kouros Owzar(Duke University)
Cited by 2
Related Papers
Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial
|The Lancet|2009|1.4k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.2k
Correlation of Kinase Genotype and Clinical Outcome in the North American Intergroup Phase III Trial of Imatinib Mesylate for Treatment of Advanced Gastrointestinal Stromal Tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group
|Journal of Clinical Oncology|2008|655